VEGF-C and VEGF-D, SASP components and mitogen factors for vascular and lymphatic endothelial cells, are increased in LAM lesions likely controlling the lymphangiogenesis and lymphatic involvement in bronchioles, and, thus, the disease progression [168, 169]. Here, VEGFD is linked to lymphangioleiomyomatosis.